First ADVENT problem statements released by EMA for monoclonal antibodies and stem cells

3 March, 2016

The EMA has now published the CVMP Ad Hoc Expert Group on Veterinary Novel Therapies (ADVENT’s) first two problem statements for public consultation:

  • Stem cell-based products for veterinary use: specific questions on sterility (Link)
  • Monoclonal antibodies for veterinary use (Link)

Further details about  guidelines being developed by ADVENT and the form for submission of comments can be found under the novel therapies section of the scientific guidelines (Link).

Business Units: 

Meet us at

Animal Health Asia

19 - 20 October 2016
Grand Hyatt Hong Kong
People's Republic of China

Go to event page